Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

• 主要な著者: Lizhong Du (著者), Xiaomei Tong (著者), Chao Chen (著者), Xirong Gao (著者), Alessandra Gagnatelli (著者), Jingyang Li (著者), Debora Santoro (著者), Sara Nicolardi (著者), Laura Fabbri (著者), The Peyona Chinese Study Group (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2020-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...